HCV-specific CD4+ proliferative responses have been repeatedly shown to be the sine qua non condition of viral clearance in acute HCV infection. While this highlights the critical importance of CD4+ T-help in the control of HCV, several urging questions remain to be answered. We still lack a comprehensive analysis of the individual HCV-specific CD4 epitopes targeted and their HLA association, which is essential information in order to understand whether certain responses are associated with a better outcome, but also to facilitate the generation of class II tetramers and functional studies on the single epitope level. Especially class II tetramer studies are required to solve what is possibly the most important question in HCV infection: Whether HCV-specific CD4+ T-cells are absent in those developing chronic infection or whether T-helper cells are present in all individuals during acute infection, but for reasons to be determined fail to proliferate and function in the majority of subjects. We have unique collaborations in place providing us with longitudinal research samples from patients with acute HCV infection and different routes of transmission, different clinical presentations and different outcomes of infection. At the same we have developed methods allowing us to define the HCV-specific CD4 response on the single epitope level in these subjects and to develop class II tetramers for direct visualization of T-helper cells and their functional and phenotypic analysis. We hypothesize that distinctions in the specificities targeted and in the dynamics of T-cell function and phenotype are leading to different outcomes of infection. Determination of the nature of the CD4+ T-cell response associated with viral control will be an important contribution to the development of HCV vaccines and immunotherapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI066345-01
Application #
7014175
Study Section
Special Emphasis Panel (ZAI1-GLM-M (M1))
Project Start
2005-07-01
Project End
2010-07-31
Budget Start
2005-07-01
Budget End
2006-07-31
Support Year
1
Fiscal Year
2005
Total Cost
$127,448
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Yu, Wen-Han; Cosgrove, Cormac; Berger, Christoph T et al. (2018) ADCC-Mediated CD56DIM NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection. Pathog Immun 3:2-18
Forconi, Catherine S; Cosgrove, Cormac P; Saikumar-Lakshmi, Pryia et al. (2018) Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas. Blood Adv 2:1101-1114
Torres-Cornejo, Almudena; Lauer, Georg M (2017) Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines. Pathog Immun 2:102-125
Vergara, C; Thio, C; Latanich, R et al. (2017) Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun 18:82-87
Wolski, David; Foote, Peter K; Chen, Diana Y et al. (2017) Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8+ T Cells in Chronic versus Acute Infection. Immunity 47:648-663.e8
Rodrigo, Chaturaka; Walker, Melanie R; Leung, Preston et al. (2017) Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. Infect Genet Evol 49:88-96
Rodrigo, C; Eltahla, A A; Bull, R A et al. (2017) Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study. J Viral Hepat 24:43-52
Rodrigo, Chaturaka; Eltahla, Auda A; Bull, Rowena A et al. (2016) Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia. J Infect Dis 214:1383-1389
Page, Kimberly; Mirzazadeh, Ali; Rice, Thomas M et al. (2016) Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis 3:ofw024
Gunn, Bronwyn; Schneider, Jeffrey; Shansab, Maryam et al. (2016) Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16. Mucosal Immunol 9:1549-1558

Showing the most recent 10 out of 57 publications